Regeneron Pharmaceuticals said its double-antibody cocktail against COVID-19 is advancing into two Phase III studies, less than a month after the start of its first clinical trial, with preliminary data from one study expected to be reported later this summer.
PacBio shares plummeted 51% on Tuesday, after it reversed its earlier “guidance” forecast to investors for 5% operating expense growth this year, revealing instead plans…
The lung cancer assembloid model can predict personalized treatments and has the potential to drive personalized lung cancer therapies.
The research study investigated how liver inflammation may block the effects of immune-boosting therapies.
For most malignancies, early tumor detection is crucial, as it expands treatment options, reduces metastases, and ultimately improves survival rates. Despite clear clinical appeal, early…
To bring single-molecule localization microscopy to everyday researchers, laboratories can upgrade existing systems or deploy all-new platforms.
University of California, San Francisco (UCSF) scientists have discovered a precursor in the blood of some people who later went on to develop multiple sclerosis…
David Julius, PhD, winner of the 2021 Nobel Prize, and researchers suggest targeting specific airway neuroendocrine cells could offer strategies for treating chronic cough associated…
Under the terms of the agreement, PathAI will make its AISight image management system available to pathology labs on the Google Cloud.
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
Gene therapy has undergone a renaissance in recent years, with several drugs offering beneficial, even life-saving treatments, now approved by the FDA. One example was…
